Xin-Ting Li

Research Progress on the Regulation of the Gut Microbiota-Metabolism Axis by Probiotics for the Treatment of Inflammatory Bowel Disease

Inflammatory bowel disease (IBD), which primarily includes ulcerative colitis (UC) and Crohn’s disease (CD), has seen a rapid rise in incidence in China in recent years. Traditional medications and biologics still face limitations such as limited targeting and a high risk of relapse upon discontinuation. Gut microbiota...